biblio
“Albumin competitively inhibits glycation of less abundant proteins”, Protein and Peptide Letters, vol. 15, no. 7, pp. 663-667, 2008.
, “Discovery of rifampicin as a new anti-glycating compound by matrix-assisted laser desorption/ionization mass spectrometry-based insulin glycation assay”, European Journal of Mass Spectrometry, vol. 16, no. 2, pp. 221-226, 2010.
, “Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes”, Journal of Proteome Research, vol. 11, no. 2, pp. 1391-1396, 2012.
, “Proteomic analysis of glycated proteins from streptozotocin-induced diabetic rat kidney”, Molecular Biotechnology, vol. 50, no. 1, pp. 28-38, 2012.
, “Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation”, Scientific Reports, vol. 3, p. 2941, 2013.
, “Molecules with O-acetyl group protect protein glycation by acetylating lysine residues”, RSC Advances, vol. 6, no. 70, pp. 65572-65578, 2016.
, “Potential dual role of eugenol in inhibiting advanced glycation end products in diabetes: proteomic and mechanistic insights”, Scientific Reports, vol. 6, 2016.
, “Proteomic insight reveals elevated levels of albumin in circulating immunecomplexes in diabetic plasma”, Molecular & Cellular Proteomics, vol. 15, no. 6, pp. 2011-2020, 2016.
,